Viatris (VTRS) Interest Expenses (2020 - 2026)
Viatris (VTRS) recorded quarterly Interest Expenses of $120.1 million in Q1 2026, little changed quarter-over-quarter from $119.6 million in Q4 2025, and up 3.98% on a YoY basis from $115.5 million in Q1 2025.
Viatris (VTRS) Interest Expenses (2020 - 2026) Analysis & Trends
Viatris' Interest Expenses history runs 7 years deep, the most recent figure standing at $120.1 million for Q1 2026.
- In Q1 2026, Interest Expenses rose 3.98% year-over-year to $120.1 million; the TTM figure through Mar 2026 stood at $475.9 million (down 9.71% YoY), while the FY2025 annual figure was $471.3 million, down 14.31% from the prior year.
- Interest Expenses was $120.1 million for Q1 2026 at Viatris, roughly flat from $119.6 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $153.2 million in Q3 2022 to a low of $115.5 million in Q1 2025.
- Historically, Interest Expenses has averaged $135.7 million across 5 years, with a median of $141.5 million in 2023.
- The sharpest annual moves came in 2025 and 2026: Interest Expenses slipped 20.03% in 2025, then increased 3.98% in 2026.
- A 5-year view of Interest Expenses shows it stood at $147.1 million in 2022, then retreated by 4.21% to $140.9 million in 2023, then dropped by 14.69% to $120.2 million in 2024, then retreated by 0.5% to $119.6 million in 2025, then increased by 0.42% to $120.1 million in 2026.
- The last three Interest Expenses figures came in at $120.1 million (Q1 2026), $119.6 million (Q4 2025), and $119.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.00 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 20.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 4.86 Mn |
| 10 | Viatris | - | - | 1.16 Bn | 120.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 120.10 Mn |
| Mar 31, 2026 | 120.10 Mn |
| Dec 31, 2025 | 119.60 Mn |
| Dec 31, 2025 | 119.60 Mn |
| Sep 30, 2025 | 119.60 Mn |
| Sep 30, 2025 | 119.60 Mn |
| Jun 30, 2025 | 116.60 Mn |
| Jun 30, 2025 | 116.60 Mn |
| Mar 31, 2025 | 115.50 Mn |
| Mar 31, 2025 | 115.50 Mn |
| Dec 31, 2024 | 120.20 Mn |
| Dec 31, 2024 | 120.20 Mn |
| Sep 30, 2024 | 145.60 Mn |
| Sep 30, 2024 | 145.60 Mn |
| Jun 30, 2024 | 145.80 Mn |
| Jun 30, 2024 | 145.80 Mn |
| Mar 31, 2024 | 138.40 Mn |
| Mar 31, 2024 | 138.40 Mn |
| Dec 31, 2023 | 140.90 Mn |
| Dec 31, 2023 | 140.90 Mn |